Literature DB >> 18261137

Indeterminate cell histiocytosis successfully treated with ultraviolet B phototherapy.

M Ishibashi1, T Ouchi, A Tanikawa, A Ishiko.   

Abstract

Indeterminate cell histiocytosis (ICH) is a rare disorder, characterized by infiltration of the skin by neoplastic cells that are characteristically positive for S-100 and CD1a, but lack Birbeck's granules. A 75-year-old man presented with a 4-year history of multiple papules on the trunk, limbs, face and neck. Skin biopsy revealed dense infiltration of histiocytic cells that were CD1a+/S100+, but lacked Birbeck's granules. No other abnormality was seen during a general examination including a computed tomography scan of the body, gallium scintigraphy, and an abdominal sonography. Broadband ultraviolet B (UVB) treatment was used for the skin lesions, and partial but almost complete remission was obtained. The case suggests that UVB phototherapy is an option for treatment of ICH.

Entities:  

Mesh:

Year:  2008        PMID: 18261137     DOI: 10.1111/j.1365-2230.2007.02667.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Generalized indeterminate cell histiocytosis successfully treated with methotrexate.

Authors:  Erina Lie; Jaroslaw Jedrych; Ronald Sweren; Michelle L Kerns
Journal:  JAAD Case Rep       Date:  2022-06-03

2.  Recurrent Indeterminate Dendritic Cell Tumor of the Skin.

Authors:  Jin Woo Joo; Taek Chung; Yoon Ah Cho; Sang Kyum Kim
Journal:  J Pathol Transl Med       Date:  2018-04-05

3.  Indeterminate cell histiocytosis successfully treated with phototherapy.

Authors:  Maria Claudia Nogueira Zerbini; Mirian Nacagami Sotto; Fernando Peixoto Ferraz de Campos; Andre Neder Ramires Abdo; Juliana Pereira; José Antônio Sanches; Jade Cury Martins
Journal:  Autops Case Rep       Date:  2016-06-30

4.  Aggressive Indeterminate Dendritic Cell Tumor Mimicking Scalp Angiosarcoma.

Authors:  Yun Li; Ting-Ting Wang; Zi-Hui Zhang; Lin Wang
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.